industry pharmaceutical founded 1993 headquarters oslo norway key people kjetil hestdal ceo bente lill rom ren chair products hexvix cysview revenue nok 93 6 million 1 number of employees 50 website www.photocure.com photocure asa is a norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology . photocure s strategy in cancer is to continue the commercialization of hexvix for bladder cancer diagnostics and continue the development of the cancer portfolio and out license prior to phase iii studies . this strategy is based on a strong platform of intellectual property in photodynamic therapy . citation needed contents 1 history 2 corporate structure 3 pharmaceuticals 4 research and development 5 references 6 external links history edit photocure was founded in 1993 and the aim was to commercialize photodynamic technologies developed by the norwegian radium hospital the largest comprehensive cancer centre in northern europe . in 1997 photocure recruited the first full time employee and started formal clinical studies for metvix . in 2000 the company filed their first marketing authorisation for metvix and the company s share were listed on the oslo stock exchange . in 2000 photocure started clinical studies on hexvix . photocure s obtained their first marketing authorisation for metvix the year after and metvix and aktilite were marketed for the first time . a licensing agreement for metvix was signed with galderma and all rights to metvix aktilite were sold to galderma in 2009 . in 2005 hexvix got approved in all eu eea countries and hexvix was launched in europe in 2006 . photocure signed a licensing agreement with ge healthcare for hexvix . hexvix was fda approved in the us in may 2010 under the trade name cysview . lumacan was licensed to salix pharmaceuticals inc. in 2010 . 2 in 27 . september 2011 photocure launched a new commercial strategy for hexvix cysview . photocure will commercialize cysview directly in the us market and continue commercialization of hexvix in the nordic countries . photocure entered into a strategic collaboration with ipsen and ipsen territory are countries outside usa and nordics . citation needed visonac is phase iii ready in 2013 and cevira clinical program is phase iii ready in 2014 . the launch of cysview by partner biosyent commenced in canada in 2015 . corporate structure edit photocure has over 50 employees and operates in norway sweden denmark finland and the us . in 2010 photocure established an us subsidiary photocure inc. pharmaceuticals edit cysview hexaminolevulinate for diagnosis of bladder cancer . cysview is marketed in europe as hexvix . research and development edit photocure was founded by the norwegian radium hospital research foundation rf to commercialise and develop technologies originally discovered by scientists at the norwegian radium hospital . references edit photocure annual report 2010 photocure signs agreement with salix pharmaceuticals for lumacan tm newsweb 22 okt 2010 external links edit official website product website http www.hexvix.com retrieved from https en.wikipedia.org w index.php title photocure & oldid 710305956 categories companies established in 1993pharmaceutical companies of norwaycompanies listed on the oslo stock exchangehidden categories all articles with unsourced statementsarticles with unsourced statements from march 2016 navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages norsk bokm l edit links this page was last modified on 16 march 2016 at 04 46 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view